000186306 001__ 186306
000186306 005__ 20240229145743.0
000186306 0247_ $$2doi$$a10.1158/1055-9965.EPI-22-0861
000186306 0247_ $$2pmid$$apmid:36512731
000186306 0247_ $$2ISSN$$a1055-9965
000186306 0247_ $$2ISSN$$a1538-7755
000186306 0247_ $$2altmetric$$aaltmetric:140212995
000186306 037__ $$aDKFZ-2022-03095
000186306 041__ $$aEnglish
000186306 082__ $$a610
000186306 1001_ $$00000-0002-4140-4488$$aLu, Yujia$$b0
000186306 245__ $$aGenetic Predictors for Fecal Propionate and Butyrate-Producing Microbiome Pathway are Not Associated with Colorectal Cancer Risk: A Mendelian Randomization Analysis.
000186306 260__ $$aPhiladelphia, Pa.$$bAACR$$c2023
000186306 3367_ $$2DRIVER$$aarticle
000186306 3367_ $$2DataCite$$aOutput Types/Journal article
000186306 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1675695840_31406
000186306 3367_ $$2BibTeX$$aARTICLE
000186306 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000186306 3367_ $$00$$2EndNote$$aJournal Article
000186306 500__ $$a2023 Feb 6;32(2):281-286
000186306 520__ $$aMechanistic data indicate the benefit of short-chain fatty acids (SCFAs) produced by gut microbial fermentation of fiber on colorectal cancer (CRC), but direct epidemiological evidence is limited. A recent study identified single nucleotide polymorphisms (SNPs) for two SCFA traits (fecal propionate and butyrate-producing microbiome pathway PWY-5022) in Europeans and showed metabolic benefits.We conducted a two-sample Mendelian randomization (MR) analysis of the genetic instruments for the two SCFA traits (three SNPs for fecal propionate and nine for PWY-5022) in relation to CRC risk in three large European genetic consortia of 58,131 CRC cases and 67,347 controls. We estimated the risk of overall CRC and conducted subgroup analyses by sex, age, and anatomical subsites of CRC.We did not observe strong evidence for an association of the genetic predictors for fecal propionate levels and the abundance of PWY-5022 with the risk of overall CRC, CRC by sex, or early-onset CRC (CRC diagnosed at <50 years), with no evidence of heterogeneity or pleiotropy. When assessed by tumor subsites, we found weak evidence for an association between PWY-5022 and risk of rectal cancer (OR per 1-SD=0.95, 95% CI=0.91-0.99; P=0.03) but it did not surpass multiple testing of subgroup analysis.Genetic instruments for fecal propionate levels and the abundance of PWY-5022 were not associated with CRC risk.Fecal propionate and PWY-5022 may not have a substantial influence on CRC risk. Future research is warranted to comprehensively investigate the effects of SCFA-producing bacteria and SCFAs on CRC risk.
000186306 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000186306 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000186306 7001_ $$00000-0001-7746-1030$$aZhao, Yu Chen$$b1
000186306 7001_ $$00000-0001-8919-1971$$aChang-Claude, Jenny$$b2
000186306 7001_ $$00000-0001-8656-7822$$aGruber, Stephen B$$b3
000186306 7001_ $$00000-0002-9795-1528$$aGsur, Andrea$$b4
000186306 7001_ $$00000-0002-2180-2032$$aOffit, Kenneth$$b5
000186306 7001_ $$00000-0002-8277-539X$$aVodickova, Ludmila$$b6
000186306 7001_ $$00000-0001-8180-418X$$aWoods, Michael O$$b7
000186306 7001_ $$00000-0002-5436-4219$$aNguyen, Long H$$b8
000186306 7001_ $$00000-0003-3362-6280$$aWade, Kaitlin H$$b9
000186306 7001_ $$00000-0002-2925-734X$$aCarreras-Torres, Robert$$b10
000186306 7001_ $$00000-0002-2818-5487$$aMoreno, Victor$$b11
000186306 7001_ $$00000-0003-2225-6675$$aBuchanan, Daniel D$$b12
000186306 7001_ $$00000-0003-2862-7895$$aCotterchio, Michelle$$b13
000186306 7001_ $$00000-0001-7284-6767$$aChan, Andrew T$$b14
000186306 7001_ $$00000-0002-1446-2201$$aPhipps, Amanda I$$b15
000186306 7001_ $$00000-0001-5666-9318$$aPeters, Ulrike$$b16
000186306 7001_ $$00000-0002-1324-0316$$aSong, Mingyang$$b17
000186306 773__ $$0PERI:(DE-600)2036781-8$$a10.1158/1055-9965.EPI-22-0861$$gp. EPI-22-0861$$n2$$p281-286$$tCancer epidemiology, biomarkers & prevention$$v32$$x1055-9965$$y2023
000186306 909CO $$ooai:inrepo02.dkfz.de:186306$$pVDB
000186306 9101_ $$0I:(DE-588b)2036810-0$$60000-0001-8919-1971$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000186306 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000186306 9141_ $$y2022
000186306 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2022-11-10
000186306 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-10
000186306 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-10
000186306 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-19
000186306 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-19
000186306 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-08-19
000186306 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-19
000186306 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-08-19
000186306 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-19
000186306 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER EPIDEM BIOMAR : 2022$$d2023-08-19
000186306 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-19
000186306 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-08-19
000186306 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000186306 980__ $$ajournal
000186306 980__ $$aVDB
000186306 980__ $$aI:(DE-He78)C020-20160331
000186306 980__ $$aUNRESTRICTED